Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation.

Area of Science:

• Biochemistry
• Molecular Biology
• Immunology

Background:

• Matrix metalloproteinases (MMPs) are enzymes involved in tissue remodeling and inflammation.
• Tissue factor pathway inhibitor (TFPI) is a key regulator of the coagulation cascade.
• The interaction between MMPs and TFPI is not fully understood.

Purpose of the Study:

• To investigate the capacity of inflammatory cell-derived MMPs to cleave TFPI.
• To determine the effect of MMP-mediated cleavage on TFPI activity.
• To explore the implications of these interactions in atherosclerotic diseases.

Main Methods:

• In vitro cleavage assays using purified MMPs (MMP-1, MMP-7, MMP-9, MMP-12) and TFPI.
• Analysis of cleavage products using NH(2)-terminal amino acid sequencing.
• Assessment of TFPI activity following proteolytic cleavage.

Main Results:

• MMP-7 and MMP-9 rapidly cleaved TFPI, primarily generating a 35-kDa product.
• MMP-1, MMP-9, and MMP-12 also cleaved TFPI into multiple fragments.
• Cleavage sites were identified, particularly near the Kunitz domains.
• Proteolytic cleavage by these MMPs significantly reduced TFPI activity.
• MMPs did not cleave key coagulation factors like tissue factor (TF), factor VII, or factor Xa.

Conclusions:

• MMPs specifically cleave TFPI, expanding their known substrate profile.
• MMP-mediated degradation of TFPI leads to a loss of anticoagulant activity.
• The co-localization of MMPs, TF, and TFPI in atherosclerotic lesions suggests a role for MMPs in modulating TF-mediated coagulation in disease.